{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:34:59Z","timestamp":1773740099495,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2019R1A2C2007455"],"award-info":[{"award-number":["2019R1A2C2007455"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.crad.2021.02.023","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T05:16:17Z","timestamp":1616390177000},"page":"550.e19-550.e28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic significance of bone marrow 2-[18F]-fluoro-2-deoxy-d-glucose uptake in diffuse large B-cell lymphoma: relation to iliac crest biopsy results"],"prefix":"10.1016","volume":"76","author":[{"given":"C.H.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.S.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Y.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.blre.2016.06.003","article-title":"Clinical approach to diffuse large B cell lymphoma","volume":"30","author":"Caimi","year":"2016","journal-title":"Blood Rev"},{"issue":"23","key":"10.1016\/j.crad.2021.02.023_bib2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.crad.2021.02.023_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.clml.2017.06.010","article-title":"Utility of bone marrow biopsy and aspirate for staging of diffuse large B cell lymphoma in the era of positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-deoxyglucose integrated with computed tomography","volume":"17","author":"Vishnu","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/annonc\/mdw137","article-title":"The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET\/CT: a Danish\u2013Canadian study","volume":"27","author":"Alzahrani","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3904\/kjim.2015.006","article-title":"Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party","volume":"31","author":"Park","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib6","first-page":"393","article-title":"Improving outcomes for patients with diffuse large B-cell lymphoma","volume":"60","author":"Flowers","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.crad.2021.02.023_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1990.8.7.1163","article-title":"Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group","volume":"8","author":"Conlan","year":"1990","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.crad.2021.02.023_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jcp.2010.080838","article-title":"Pitfalls in bone marrow pathology: avoiding errors in bone marrow trephine biopsy diagnosis","volume":"64","author":"Wilkins","year":"2011","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.crad.2021.02.023_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jcp.2010.080820","article-title":"Pitfalls in obtaining and interpreting bone marrow aspirates: to err is human","volume":"64","author":"Bain","year":"2011","journal-title":"J Clin Pathol"},{"issue":"9","key":"10.1016\/j.crad.2021.02.023_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.annonc.2020.05.016","article-title":"Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M\/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial","volume":"31","author":"McMillan","year":"2020","journal-title":"Ann Oncol"},{"issue":"27","key":"10.1016\/j.crad.2021.02.023_bib11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.crad.2021.02.023_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00259-008-1021-9","article-title":"Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate","volume":"36","author":"Paone","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.crad.2021.02.023_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","article-title":"PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement","volume":"122","author":"Khan","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.crad.2021.02.023_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2967\/jnumed.113.134486","article-title":"Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma","volume":"55","author":"Cerci","year":"2014","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.crad.2021.02.023_bib15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","article-title":"In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy","volume":"54","author":"Berthet","year":"2013","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.crad.2021.02.023_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00277-011-1353-6","article-title":"Role of FDG-PET\/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma","volume":"91","author":"Hong","year":"2012","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.crad.2021.02.023_bib17","first-page":"361","article-title":"Prognostic importance of bone marrow uptake on baseline (18)F-FDG positron emission tomography in diffuse large B cell lymphoma","volume":"31","author":"Soydal","year":"2016","journal-title":"Cancer Biother Radiopharm"},{"issue":"14","key":"10.1016\/j.crad.2021.02.023_bib18","doi-asserted-by":"crossref","first-page":"19072","DOI":"10.18632\/oncotarget.7616","article-title":"Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma","volume":"7","author":"Liang","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.crad.2021.02.023_bib19","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cam4.1205","article-title":"Bone marrow biopsy superiority over PET\/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma","volume":"6","author":"Chen-Liang","year":"2017","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.crad.2021.02.023_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2007-01-070300","article-title":"Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index","volume":"110","author":"Chung","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0609.2006.00644.x","article-title":"The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement","volume":"76","author":"Campbell","year":"2006","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.crad.2021.02.023_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jcp.44.4.350","article-title":"Bone marrow biopsy in non-Hodgkin's lymphoma","volume":"44","author":"Roath","year":"1991","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1016\/j.crad.2021.02.023_bib23","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0284185117701305","article-title":"Use of FDG PET\/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy","volume":"58","author":"Teagle","year":"2017","journal-title":"Acta Radiol"},{"issue":"3","key":"10.1016\/j.crad.2021.02.023_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","article-title":"FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis","volume":"41","author":"Adams","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.crad.2021.02.023_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-82-3-365","article-title":"Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases","volume":"82","author":"Brunning","year":"1975","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.blre.2015.06.003","article-title":"Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma","volume":"29","author":"Adams","year":"2015","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J Anesthesiol"},{"issue":"6","key":"10.1016\/j.crad.2021.02.023_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.crad.2021.02.023_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00259-017-3915-x","article-title":"Correction to: diagnostic and prognostic value of baseline FDG PET\/CT skeletal textural features in diffuse large B cell lymphoma","volume":"45","author":"Aide","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.crad.2021.02.023_bib30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.7150\/jca.23714","article-title":"Prognostic value of bone marrow FDG uptake pattern of PET\/CT in newly diagnosed diffuse large B-cell lymphoma","volume":"9","author":"Chen","year":"2018","journal-title":"J Cancer"},{"issue":"45","key":"10.1016\/j.crad.2021.02.023_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008655","article-title":"Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography\/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy","volume":"96","author":"Chang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.crad.2021.02.023_bib32","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1186\/s12885-018-5104-0","article-title":"Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using (18)F-FDG PET\/CT and\/or routine iliac crest biopsy? A new approach of PET\/CT-guided targeted bone marrow biopsy","volume":"18","author":"Hao","year":"2018","journal-title":"BMC Cancer"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926021001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:44:34Z","timestamp":1757868274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926021001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0009926021001549"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2021.02.023","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of bone marrow 2-[18F]-fluoro-2-deoxy-d-glucose uptake in diffuse large B-cell lymphoma: relation to iliac crest biopsy results","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2021.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}